Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study

Introduction Chronic lower back pain is a common report in the general population. A dysfunctional sacroiliac joint (SIJ) is estimated to be responsible for one in five patients with lower back pain. Minimally invasive sacroiliac joint fusion (MISJF) is a surgical procedure to treat SIJ dysfunction....

Full description

Saved in:
Bibliographic Details
Main Authors: Kris L L Movig, Sem M M Hermans, Jorm M Nellensteijn, Henk van Santbrink, Rob Knoef, Mattheus K Reinders, Daisy M N Hoofwijk, Jan W Potters, Inez Curfs, Wouter L W van Hemert
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e056204.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850066482840469504
author Kris L L Movig
Sem M M Hermans
Jorm M Nellensteijn
Henk van Santbrink
Rob Knoef
Mattheus K Reinders
Daisy M N Hoofwijk
Jan W Potters
Inez Curfs
Wouter L W van Hemert
author_facet Kris L L Movig
Sem M M Hermans
Jorm M Nellensteijn
Henk van Santbrink
Rob Knoef
Mattheus K Reinders
Daisy M N Hoofwijk
Jan W Potters
Inez Curfs
Wouter L W van Hemert
author_sort Kris L L Movig
collection DOAJ
description Introduction Chronic lower back pain is a common report in the general population. A dysfunctional sacroiliac joint (SIJ) is estimated to be responsible for one in five patients with lower back pain. Minimally invasive sacroiliac joint fusion (MISJF) is a surgical procedure to treat SIJ dysfunction. During the procedure, the SIJ is stabilised by implants inserted percutaneously under fluoroscopy guidance. Postoperatively, patients often report a lot of pain, which contributes to patients taking high doses of painkillers (opioids for example,) and preventing early mobilisation. In several orthopaedic procedures, intraoperative infiltration of the wound bed results in decreased consumption of analgesics, earlier mobilisation and shorter hospitalisation time. The aim of this study is to investigate the effectiveness of intraoperative SIJ infiltration with analgesia in reducing postoperative pain after MISJF.Methods and analysis We will perform a two-centre, prospective, double-blind, randomised controlled trial to determine whether SIJ infiltration with 1.5–5 cc bupivacaine 0.50% is superior to 1.5–5 cc placebo (NaCl 0.9%) in reducing postoperative pain in patients after MISJF, and to determine whether bupivacaine significantly reduces opioid use in the direct postoperative period. Patients will be randomised with 1:1 allocation for either bupivacaine (intervention) or placebo SIJ infiltration. Postoperative pain will be measured by the Visual Analogue Scale pain score at entry and exit recovery, 2, 4, 6, 24 and 48 hours postoperatively.Ethics and dissemination This is the first trial that investigates the effectiveness of intraoperative SIJ infiltration with bupivacaine 0.50% in reducing postoperative pain after MISJF. If intraoperative SIJ infiltration with bupivacaine 0.50% proves to be effective, this might have important clinical implications, such as postoperative analgesics (opioids for example,) consumption, earlier mobilisation and potentially shorter hospitalisation time.Trial registration number NL9151.
format Article
id doaj-art-8f0b6237b23d453abeb199783a0ecf53
institution DOAJ
issn 2044-6055
language English
publishDate 2021-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-8f0b6237b23d453abeb199783a0ecf532025-08-20T02:48:43ZengBMJ Publishing GroupBMJ Open2044-60552021-12-01111210.1136/bmjopen-2021-056204Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS studyKris L L Movig0Sem M M Hermans1Jorm M Nellensteijn2Henk van Santbrink3Rob Knoef4Mattheus K Reinders5Daisy M N Hoofwijk6Jan W Potters7Inez Curfs8Wouter L W van Hemert9Department of Clinical Pharmacy, Medical Spectrum Twente, Enschede, NetherlandsCaphri School of Public Health an Primary Care, Maastricht University, Maastricht, The NetherlandsOrthopaedic Surgery, Medical Spectrum Twente, Enschede, NetherlandsDepartment of Neurosurgery, Maastricht University Medical Centre+, Maastricht, Limburg, The NetherlandsOrthopaedic Surgery, Medical Spectrum Twente, Enschede, NetherlandsClinical Pharmacy, Pharmacology and Toxicology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, NetherlandsAnaesthesiology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, NetherlandsAnaesthesiology, Medical Spectrum Twente, Enschede, Netherlands14 Department of Orthopaedic Surgery and Traumatology, Zuyderland Medical Centre, Heerlen, The NetherlandsDepartment of Orthopedic Surgery and Traumatology, Zuyderland Medical Centre Heerlen, Heerlen, The NetherlandsIntroduction Chronic lower back pain is a common report in the general population. A dysfunctional sacroiliac joint (SIJ) is estimated to be responsible for one in five patients with lower back pain. Minimally invasive sacroiliac joint fusion (MISJF) is a surgical procedure to treat SIJ dysfunction. During the procedure, the SIJ is stabilised by implants inserted percutaneously under fluoroscopy guidance. Postoperatively, patients often report a lot of pain, which contributes to patients taking high doses of painkillers (opioids for example,) and preventing early mobilisation. In several orthopaedic procedures, intraoperative infiltration of the wound bed results in decreased consumption of analgesics, earlier mobilisation and shorter hospitalisation time. The aim of this study is to investigate the effectiveness of intraoperative SIJ infiltration with analgesia in reducing postoperative pain after MISJF.Methods and analysis We will perform a two-centre, prospective, double-blind, randomised controlled trial to determine whether SIJ infiltration with 1.5–5 cc bupivacaine 0.50% is superior to 1.5–5 cc placebo (NaCl 0.9%) in reducing postoperative pain in patients after MISJF, and to determine whether bupivacaine significantly reduces opioid use in the direct postoperative period. Patients will be randomised with 1:1 allocation for either bupivacaine (intervention) or placebo SIJ infiltration. Postoperative pain will be measured by the Visual Analogue Scale pain score at entry and exit recovery, 2, 4, 6, 24 and 48 hours postoperatively.Ethics and dissemination This is the first trial that investigates the effectiveness of intraoperative SIJ infiltration with bupivacaine 0.50% in reducing postoperative pain after MISJF. If intraoperative SIJ infiltration with bupivacaine 0.50% proves to be effective, this might have important clinical implications, such as postoperative analgesics (opioids for example,) consumption, earlier mobilisation and potentially shorter hospitalisation time.Trial registration number NL9151.https://bmjopen.bmj.com/content/11/12/e056204.full
spellingShingle Kris L L Movig
Sem M M Hermans
Jorm M Nellensteijn
Henk van Santbrink
Rob Knoef
Mattheus K Reinders
Daisy M N Hoofwijk
Jan W Potters
Inez Curfs
Wouter L W van Hemert
Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study
BMJ Open
title Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study
title_full Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study
title_fullStr Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study
title_full_unstemmed Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study
title_short Study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion: the ARTEMIS study
title_sort study protocol for a randomised controlled trial on the effect of local analgesia for pain relief after minimal invasive sacroiliac joint fusion the artemis study
url https://bmjopen.bmj.com/content/11/12/e056204.full
work_keys_str_mv AT krisllmovig studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT semmmhermans studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT jormmnellensteijn studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT henkvansantbrink studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT robknoef studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT mattheuskreinders studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT daisymnhoofwijk studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT janwpotters studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT inezcurfs studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy
AT wouterlwvanhemert studyprotocolforarandomisedcontrolledtrialontheeffectoflocalanalgesiaforpainreliefafterminimalinvasivesacroiliacjointfusiontheartemisstudy